Nutriband Inc. (NTRB) is an innovative healthcare company that specializes in the development and distribution of world-class pharmaceutical and wellness products. Pioneering in the transdermal delivery market, Nutriband Inc. utilizes the human skin as a pathway for delivering compounds and enhancing or improving molecular potency.
Founded in 2012, Nutriband Inc. is headquartered in Orlando, Florida. Under the leadership of CEO Gareth Sheridan, the company has pursued a different approach in the pharmaceutical industry, aiming to mitigate the potential risks and limitations of oral delivery systems. With Gareth's vision and strategic direction, Nutriband has been successful in revolutionizing the way in which drugs and vitamins are administered, and its groundbreaking technologies have gained recognition and patent-approvals on an international scale.
Nutriband’s product line is anchored on their proprietary transdermal technology, which is a unique and safe method of delivering drugs and therapeutic agents across the skin for systemic distribution. This distinctive method of delivery has various benefits over traditional oral delivery systems, including improved patient compliance, reduced side effects, and sustained drug levels in the bloodstream.
Over the years, Nutriband Inc. has demonstrated an impressive performance as a forward-thinking pharmaceutical company. It has acquired a number of companies to expand its portfolio, including 4P's Therapeutics, a transdermal drug delivery company, and Carmel Biosciences, known for its FDA-approved heart disease drug, PREXXARTAN™.
Among its game-changing line of products is the abuse-deterrent fentanyl patch, which is designed to address opioid abuse – a serious public health issue in the US. By using this technology, the risk of non-medical opioid use, accidental exposure, and ingestion by children can be significantly lowered. The company aims to address the opioid epidemic through scientifically-backed solutions.
Nutriband Inc.'s innovative and patient-focused approach has made the company the forefront of advanced pharmaceutical technology. It continues to drive transformation in the healthcare industry, providing practical solutions to major problems, and constantly striving to enhance patients' quality of life. With its continuous research and development, Nutriband Inc. is on track to creating more groundbreaking solutions that will redefine the dynamics of drug and vitamin administration in the future.